Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study

Hamill, Victoria; Wong, Stanley; Benselin, Jennifer; Krajden, Mel; Hayes, Peter C; Mutimer, David; Yu, Amanda; Dillon, John F; Gelson, William; Velásquez García, Hector A; Yeung, Alan; Johnson, Philip; Barclay, Stephen T; Alvarez, Maria; Toyoda, Hidenori; Agarwal, Kosh; Fraser, Andrew; Bartlett, Sofia; Aldersley, Mark; Bathgate, Andy; Binka, Mawuena; Richardson, Paul; Morling, Joanne R; Ryder, Stephen D; MacDonald, Douglas; Hutchinson, Sharon; Barnes, Eleanor; Guha, Indra Neil; Irving, William L; Janjua, Naveed Z; Innes, Hamish

doi:10.1136/bmj-2022-074001

All Outputs (1)

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study (2023)
Journal Article
Hamill, V., Wong, S., Benselin, J., Krajden, M., Hayes, P. C., Mutimer, D., …Innes, H. (2023). Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study. BMJ, 382, Article e074001. https://doi.org/10.1136/bmj-2022-074001

Objectives To quantify mortality rates for patients successfully treated for hepatitis C in the era of interferon-free, direct acting antivirals and compare these rates with those of the general population.

Design Population based cohort study.... Read More about Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.